CTRI/2023/02/049718
Not yet recruiting
Phase 3
Open Labeled Randomized Controlled Trial To Compare The Effect Of Snuhi Ksheer Haridra Churna Alepa And Sclerotherapy in the Reduction of Size of Arsha With Special Reference To Grade || and ||| Degree Haemorrhoids
Dr Akanksha Ravindra Rangari0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: K641- Second degree hemorrhoids
- Sponsor
- Dr Akanksha Ravindra Rangari
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Diagnosed patients of II and III degree haemorrhoids in the age group of 18\-60 yrs.
- •2\) Selection will be irrespective of gender, religion, education and socio\-economic status of the patients.
Exclusion Criteria
- •1\) Patients with grade I and IV degree haemorrhoids.
- •2\) Patients suffering from different pathologies of anal canal and rectum like carcinoma rectum and anal canal, ulcerative colitis,proctitis etc.
- •3\) Patients with uncontrolled diabetes mellitus, immune\-compromised patients
- •4\) Known patients of portal hypertension will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Treatment of Heelpain by Agnikarma and Vidhya AgnikarmaCTRI/2023/02/049952Dr Anjali Subhashrao Suryawanshi
Not yet recruiting
Not Applicable
EVETERACETAM VS SODIUM VALPROATEHealth Condition 1: G409- Epilepsy, unspecifiedCTRI/2020/09/027792government medical college and hospital aurangabad
Active, not recruiting
Not Applicable
Randomised, controlled open label trial to compare the efficacy safety and tolerability of a treatment simplification by darunavir/ritonavir DRV/r 800/100 mg OD vs a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments - TMC114HIV3006HIV-1 patients with plasma RNA HIV-1 undetectable in current treatmentMedDRA version: 9.1Level: LLTClassification code 10049829Term: Blood HIV RNA below assay limitEUCTR2006-006437-40-ITJANSSEN-CILAG INTERNATIONAL N.V.250
Active, not recruiting
Phase 1
Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous access devices - RCT for the prevention of early CVAD InfectioPotential Systematic SepsisEUCTR2006-000675-15-GBGreat Ormond Street Hospital for Children NHS Trust500
Active, not recruiting
Phase 1
A trial comparing the effect of ceftriaxone plus azithromycin versus ceftriaxone for the treatment of Neisseria gonorrhoeae on the resistance geneseisseria gonorrhoeae (Ng)MedDRA version: 21.1Level: LLTClassification code 10051970Term: Neisseria gonorrhoeae infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2021-003616-10-BEInstitute of Tropical Medicine42